Ki-young Lee

Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications

Targeting a genomic RNA G-quadruplex of dengue virus with small molecules as an alternative to protein-targeted therapeutics.

Targeting a genomic RNA G-quadruplex of dengue virus with small molecules as an alternative to protein-targeted therapeutics.

Journal: Journal of biomedical science
Published: December 09, 2025

Integrative structural and dynamics studies of epidermal growth factor receptor (EGFR).

Integrative structural and dynamics studies of epidermal growth factor receptor (EGFR).

Journal: Experimental & molecular medicine
Published: December 02, 2025

Tumor-intrinsic PD-L1 drives lung cancer progression in response to TLR stimulation by promoting autophagy through the TRAF6-BECN1 signaling axis.

Tumor-intrinsic PD-L1 drives lung cancer progression in response to TLR stimulation by promoting autophagy through the TRAF6-BECN1 signaling axis.

Journal: Experimental hematology & oncology
Published: November 27, 2025

IFI35 suppresses the transcription of hepatitis B virus cccDNA minichromosome via promoting HNF4α proteasomal degradation.

IFI35 suppresses the transcription of hepatitis B virus cccDNA minichromosome via promoting HNF4α proteasomal degradation.

Journal: Journal of biomedical science
Published: October 22, 2025

USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis.

USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis.

Journal: Cell death & disease
Published: June 05, 2025

TXNIP Suppresses Lung Cancer Progression by Inhibiting TRAF6-Mediated NF-κB Activation and Autophagy.

TXNIP Suppresses Lung Cancer Progression by Inhibiting TRAF6-Mediated NF-κB Activation and Autophagy.

Journal: Immune network
Published: June 02, 2025

USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition.

USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition.

Journal: Biomarker research
Published: April 01, 2025

Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases.

Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 02, 2025

PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways.

PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways.

Journal: Experimental & molecular medicine
Published: January 08, 2025

USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer.

USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer.

Journal: Cell death discovery
Published: October 17, 2024

PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals.

PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals.

Journal: Biomarker research
Published: April 18, 2024

DNA binding reveals hidden interdomain allostery of a MazE antitoxin from Mycobacterium tuberculosis.

DNA binding reveals hidden interdomain allostery of a MazE antitoxin from Mycobacterium tuberculosis.

Journal: Biochemical and biophysical research communications
Published: March 17, 2024
Showing 1-12 of 94

Last Updated: 09/26/2026